1. Home
  2. FBIN vs GKOS Comparison

FBIN vs GKOS Comparison

Compare FBIN & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

N/A

Current Price

$45.25

Market Cap

6.2B

ML Signal

N/A

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$103.96

Market Cap

6.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FBIN
GKOS
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.9B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
FBIN
GKOS
Price
$45.25
$103.96
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$61.40
$133.07
AVG Volume (30 Days)
3.4M
662.2K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
2.30%
N/A
EPS Growth
N/A
N/A
EPS
2.47
N/A
Revenue
$4,463,200,000.00
$507,442,000.00
Revenue This Year
$2.75
$23.39
Revenue Next Year
$3.64
$27.46
P/E Ratio
$18.34
N/A
Revenue Growth
N/A
32.33
52 Week Low
$44.04
$73.16
52 Week High
$64.84
$130.23

Technical Indicators

Market Signals
Indicator
FBIN
GKOS
Relative Strength Index (RSI) 28.50 35.28
Support Level $44.04 $81.54
Resistance Level $53.81 $106.52
Average True Range (ATR) 2.11 3.58
MACD -1.04 -1.81
Stochastic Oscillator 7.67 14.28

Price Performance

Historical Comparison
FBIN
GKOS

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: